Background: Continuous glucose monitors (CGMs), sensor-augmented pumps (SAPs), and automated insulin delivery (AID) systems have substantially improved glycemic outcomes for people with type 1 diabetes (T1D).
Background: Continuous glucose monitors (CGMs), sensor-augmented pumps (SAPs), and automated insulin delivery (AID) systems have substantially improved glycemic outcomes for people with type 1 diabetes (T1D).